SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Conversely, models such as SCN1A mutant mice (Dravet syndrome) demonstrate limited or variable responses to GABA-T inhibition because their underlying pathology reflects sodium channel dysfunction rather than primary deficits in GABAergic inhibition [119].